CS7017

CS7017 · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CS7017, covering 2020-09-16 to 2020-09-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel [Phase 1, Phase 2]